CARDLYTICS INC's ticker is CDLX and the CUSIP is 14161W105. A total of 124 filers reported holding CARDLYTICS INC in Q4 2022. The put-call ratio across all filers is 1.89 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,950 | +161.1% | 300 | 0.0% | 0.00% | – |
| Q2 2023 | $1,896 | +86.1% | 300 | 0.0% | 0.00% | – |
| Q1 2023 | $1,019 | -66.0% | 300 | -23.1% | 0.00% | – |
| Q4 2022 | $3,000 | 0.0% | 390 | +25.8% | 0.00% | – |
| Q3 2022 | $3,000 | -57.1% | 310 | +1.6% | 0.00% | – |
| Q2 2022 | $7,000 | -56.2% | 305 | -1.3% | 0.00% | – |
| Q1 2022 | $16,000 | -40.7% | 309 | -21.8% | 0.00% | – |
| Q4 2021 | $27,000 | -10.0% | 395 | +11.6% | 0.00% | – |
| Q3 2021 | $30,000 | -64.3% | 354 | -46.7% | 0.00% | – |
| Q2 2021 | $84,000 | -53.8% | 664 | -57.7% | 0.00% | – |
| Q1 2021 | $182,000 | -89.2% | 1,570 | -86.7% | 0.00% | -100.0% |
| Q4 2020 | $1,688,000 | +1123.2% | 11,831 | +508.3% | 0.01% | – |
| Q3 2020 | $138,000 | -2.8% | 1,945 | -5.3% | 0.00% | – |
| Q2 2020 | $142,000 | +688.9% | 2,053 | +297.9% | 0.00% | – |
| Q1 2020 | $18,000 | – | 516 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners VIII LLC | 1,133,141 | $29,439,000 | 58.62% |
| Polaris Venture Management Co. V, L.L.C. | 2,277,342 | $59,165,000 | 46.48% |
| CAS Investment Partners, LLC | 2,162,020 | $56,169,000 | 14.39% |
| Cannell Capital | 626,975 | $16,289,000 | 4.62% |
| Antipodean Advisors LLC | 142,358 | $3,698,000 | 4.50% |
| Shannon River Fund Management LLC | 344,230 | $8,943,000 | 1.42% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 19,048 | $495,000 | 1.40% |
| Tygh Capital Management, Inc. | 176,237 | $4,579,000 | 0.78% |
| Penn Capital Management Company, LLC | 263,499 | $6,846,000 | 0.68% |
| EAM Global Investors LLC | 56,866 | $1,477,000 | 0.63% |